Actively Recruiting
Nasal Obstruction and Olfactory Losses
Led by Ohio State University · Updated on 2025-03-19
330
Participants Needed
1
Research Sites
309 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
About 13% of US adults, some 30 million people, suffer from nasal sinus disease. Although nasal obstruction and smell loss are two of the major symptoms of the disease that are crucial to disease management, currently there is a lack of clinical tools to effectively evaluate the mechanisms contributing to these symptoms. The proposed study aims to develop novel clinical tools to better evaluate and relieve patients' nasal obstructive symptoms and to enable patients and clinicians to make more informed, personalized decisions regarding treatment strategy.
CONDITIONS
Official Title
Nasal Obstruction and Olfactory Losses
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Smell loss complaints
- Nasal obstruction
You will not qualify if you...
- Congenital olfactory losses
- Nasal polyps blocking the olfactory cleft
- Significant atrophy
- Cystic fibrosis
- Wegener's or any other connective tissue disorder
- Head trauma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eye and Ear Institute, 915 Olentangy River Road, ENT, Suite 4000
Columbus, Ohio, United States, 43212
Actively Recruiting
Research Team
V
Veronica Formanek, BS
CONTACT
B
Beth Miles-Markley, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here